Buy Verzenio 150mg Online
We are pleased to introduce Verzenio 150mg, a prescription medication designed to treat certain types of cancer. Verzenio is a highly effective and well-established treatment option that can make a difference in the lives of patients fighting cancer.
Product Description:
Verzenio 150mg is an oral medication that belongs to a class of drugs called CDK4/6 inhibitors. It is specifically indicated for the treatment of advanced or metastatic breast cancer that is hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), and has progressed despite endocrine therapy.
Key Features and Benefits:
- Targeted Cancer Treatment: Verzenio 150mg is designed to target and inhibit specific proteins known as cyclin-dependent kinases 4 and 6 (CDK4/6) within cancer cells. By doing so, it helps to slow down the growth and division of cancer cells, reducing the progression and spread of the disease.
- HR+ Breast Cancer Treatment: Verzenio is particularly effective in treating hormone receptor-positive (HR+) breast cancer, which accounts for a significant portion of breast cancer cases. It is used in combination with endocrine therapy or as a standalone treatment, depending on the specific situation and the advice of the prescribing healthcare professional.
- Extended Progression-Free Survival: Verzenio has demonstrated its efficacy in extending progression-free survival (PFS) in patients with advanced or metastatic HR+ breast cancer. PFS refers to the duration of time during which the disease does not worsen, providing patients with more time to fight the cancer and potentially improving overall outcomes.
- Well-Tolerated Treatment Option: Verzenio is generally well-tolerated by patients, and its side effects can be managed with appropriate medical care. As with any medication, it is important to discuss potential side effects with the prescribing healthcare professional and promptly report any concerns during treatment.
- Prescription Medication: Verzenio 150mg is a prescription medication that should only be used under the guidance and supervision of a qualified healthcare professional. It is important to follow the prescribed dosage and administration instructions to ensure the best possible results and minimize potential risks.
Usage Instructions:
Verzenio 150mg should be taken exactly as prescribed by the healthcare professional. The dosage and treatment duration will be determined based on the individual patient’s condition, medical history, and response to therapy. It is important to follow all instructions provided by the healthcare professional and seek clarification if any doubts or concerns arise during treatment.
Why Choose Verzenio 150mg:
- Established Efficacy: Verzenio 150mg has been extensively studied and proven to be effective in the treatment of advanced or metastatic HR+ breast cancer. Its efficacy has been demonstrated through rigorous clinical trials and real-world experience, making it a trusted treatment option.
- Quality and Safety: Equicurepharm prioritizes the quality and safety of all pharmaceutical products. We source Verzenio 150mg from reputable manufacturers and ensure that it meets strict quality standards, providing you with a reliable and authentic medication.
- Secure and Confidential Ordering: We understand the importance of privacy when it comes to ordering medications. Equicurepharm offers secure and confidential ordering, ensuring that your personal information is protected throughout the process.
- Responsive Customer Support: Equicurepharm is committed to providing excellent customer support. If you have any questions, concerns, or require assistance regarding Verzenio 150mg or any other product, our dedicated customer support team is available to assist you.
Fight back against advanced or metastatic HR+ breast cancer with Verzenio 150mg, a targeted and effective treatment option. Consult with your healthcare professional, follow their guidance, and place your order today to access this important medication. Together, we can make a difference in your fight against cancer.
VERZENIO 150mg Tablets ( Abemaciclib 150 mg )
VERZENIO™ (abemaciclib) is indicated:
- in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
- in combination with fulvestrant for the treatment of women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.
- as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting.
Verzenio 150mg DOSAGE AND ADMINISTRATION
Recommended Dose And Schedule
When used in combination with fulvestrant or an aromatase inhibitor, the recommended dose of VERZENIO is 150 mg taken orally twice daily.
- When given with VERZENIO, refer to the Full Prescribing Information for the recommended dose of the aromatase inhibitor being used.
- When given with VERZENIO, the recommended dose of fulvestrant is 500 mg administered on Days 1, 15, and 29; and once monthly thereafter. Refer to the Full Prescribing Information for fulvestrant. Pre/perimenopausal women treated with the combination of VERZENIO plus fulvestrant should be treated with a gonadotropin-releasing hormone agonist according to current clinical practice standards.
When used as monotherapy, the recommended dose of VERZENIO is 200 mg taken orally twice daily.
Continue treatment until disease progression or unacceptable toxicity. VERZENIO may be taken with or without food.
Instruct patients to take their doses of VERZENIO at approximately the same times every day.
If the patient vomits or misses a dose of VERZENIO, instruct the patient to take the next dose at its scheduled time. Instruct patients to swallow VERZENIO tablets whole and not to chew, crush, or split tablets before swallowing. Instruct patients not to ingest VERZENIO tablets if broken, cracked, or otherwise not intact.
Reviews
There are no reviews yet.